Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
Kisako FujiwaraTakayuki KondoKentaro FujimotoSae YumitaKeita OgawaTakamasa IshinoMiyuki NakagawaTerunao IwanagaSatoshi TsuchiyaKeisuke KorokiHiroaki KanzakiMasanori InoueKazufumi KobayashiSoichiro KiyonoMasato NakamuraNaoya KanogawaSadahisa OgasawaraShingo NakamotoTetsuhiro ChibaJun KoizumiJun KatoNaoya KatoPublished in: Journal of gastroenterology (2024)
Careful management is warranted for patients with risk factors for exacerbation of PH-related complications; moreover, the effective use of CECT is clinically important.